68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

NCT03113617 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Stage II Prostate Adenocarcinoma
Stage III Prostate Adenocarcinoma
Stage IV Prostate Adenocarcinoma

Interventions

PROCEDURE: Computed Tomography
DRUG: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Positron Emission Tomography

Sponsor

Andrei Iagaru